1. Home
  2. Labeler Index
  3. Gland Pharma Limited
  4. 68083-155
  5. NDC Package Code: 68083-155-01 Plerixafor

NDC Package 68083-155-01 Plerixafor

Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68083-155-01
Package Description:
1 VIAL in 1 CARTON / 1.2 mL in 1 VIAL
Product Code:
68083-155
Proprietary Name:
Plerixafor
Non-Proprietary Name:
Plerixafor
Substance Name:
Plerixafor
Usage Information:
Plerixafor is used by patients with certain types of cancer (non-Hodgkin's lymphoma-NHL, multiple myeloma-MM) to prepare them for stem cell transplant. Stem cells, which are found mainly in the bone marrow, turn into red blood cells, white blood cells, and platelets. Plerixafor is used to help stem cells move from the bone marrow to the bloodstream so that the cells can be collected and stored. The stem cells are then infused back into the patient after chemotherapy or radiation.
11-Digit NDC Billing Format:
68083015501
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Gland Pharma Limited
Dosage Form:
Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
Administration Route(s):
Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s):
PLERIXAFOR 24 mg/1.2mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA206644
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
05-03-2024
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 68083-155-01?

The NDC Packaged Code 68083-155-01 is assigned to a package of 1 vial in 1 carton / 1.2 ml in 1 vial of Plerixafor, a human prescription drug labeled by Gland Pharma Limited. The product's dosage form is injection, solution and is administered via subcutaneous form.

Is NDC 68083-155 included in the NDC Directory?

Yes, Plerixafor with product code 68083-155 is active and included in the NDC Directory. The product was first marketed by Gland Pharma Limited on May 03, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 68083-155-01?

The 11-digit format is 68083015501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-268083-155-015-4-268083-0155-01